These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7449741)

  • 1. Estrogen binding component of mouse Leydig cell tumor: an in vitro conversion from nonreceptor to receptor-like molecule.
    Sato B; Maeda Y; Noma K; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Feb; 108(2):612-9. PubMed ID: 7449741
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B; Spomer W; Huseby RA; Samuels LT
    Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of estrogen receptors in various mouse Leydig cell tumor lines.
    Sato B; Huseby RA; Samuels LT
    Cancer Res; 1978 Sep; 38(9):2842-7. PubMed ID: 679191
    [No Abstract]   [Full Text] [Related]  

  • 5. Estradiol receptor levels in spontaneous Leydig cell tumors of Fischer rats.
    Dubé JY; Tremblay RR; Frenette G; Lesage R; Tremblay M
    J Steroid Biochem; 1980 Jun; 13(6):573-6. PubMed ID: 7382497
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence of a small molecule in mouse Leydig cell tumors which inhibits the conversion of estrogen receptor from 4S to 5S.
    Sato B; Huseby RA; Samuels LT
    Endocrinology; 1978 Feb; 102(2):545-55. PubMed ID: 743977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL; Huseby RA; Wilcox RB
    Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of 3 H-estradiol in transplanted interstitial cell tumors in mice.
    Bollengier WE; Eisenfeld AJ; Gardner WU
    J Natl Cancer Inst; 1973 Jan; 50(1):195-200. PubMed ID: 4692860
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological and biochemical characterization of estrogen-dependent mouse Leydig cell tumors.
    Sato B; Miyashita Y; Nishizawa Y; Noma K; Kishimoto S; Mori H; Matsumoto K
    J Steroid Biochem; 1987; 27(1-3):421-9. PubMed ID: 3695489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative changes in estrogen receptor produced by chronic DES treatment of two mouse strains differing in susceptibility to Leydig cell tumor induction.
    Terakawa N; Huseby RA; Fang SM; Samuels LT
    J Steroid Biochem; 1982 May; 16(5):643-52. PubMed ID: 7201547
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic AMP-dependent and -independent protein phosphokinase activity in subcellular fractions of synchronously growing leydig I-10 cells.
    Christensen M; Schweppe JS; Jungmann RA
    Exp Cell Res; 1979 Nov; 124(1):15-24. PubMed ID: 227706
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of estrogen receptor-like high affinity components by exposure of cytosols from mouse Leydig cell tumor or male rat liver to chaotropic salts.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Matsumoto K; Yamamura Y
    J Steroid Biochem; 1981 Jun; 14(7):619-24. PubMed ID: 7265965
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
    Sato B; Maeda Y; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
    Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of an estrogen-dependent early steroidogenic lesion in murine Leydig tumor cells.
    Zimniski SJ; Melner MH; Puett D
    Endocrinology; 1985 Jun; 116(6):2583-91. PubMed ID: 3996327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the role of estrogen-related receptors α, β and γ in tumor Leydig cells.
    Kotula-Balak M; Milon A; Pawlicki P; Opydo-Chanek M; Pacwa A; Lesniak K; Sekula M; Zarzycka M; Bubka M; Tworzydlo W; Bilinska B; Hejmej A
    Tissue Cell; 2018 Jun; 52():78-91. PubMed ID: 29857832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal induction of specific protein synthesis in murine Leydig tumor cells.
    Melner MH; Puett D
    Biochem Int; 1985 May; 10(5):763-70. PubMed ID: 3874624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
    Kurland G; Christensen AK; Huseby RA
    Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of receptor-bound human choriogonadotropin by murine Leydig tumor cells.
    Ascoli M; Puett D
    J Biol Chem; 1978 Jul; 253(14):4892-9. PubMed ID: 209021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.